About Wyeth

Wyeth is a global leader in pharmaceuticals, consumer health care products, and animal health care products and improves the lives of millions of people around the world with its outstanding products. The company exploits in the discovery, development, manufacture, and sale of various line of products in three divisions: Wyeth Pharmaceuticals, Wyeth Consumer Health Care, and Fort Dodge Animal Health. Wyeth Pharmaceuticals manufactures, distributes, and sells leading products in the areas of women's health care, neuroscience, cardiovascular therapy, vaccines and infectious disease, and is a leader in the development of nutritionals. Wyeth Consumer Health Care products include analgesics, cough/cold/allergy remedies, nutritional supplements, and other relief supplements sold over-the-counter. Three of their product lines, Advil, Centrum, and Robitussin, are among the top 12 non-prescription medicines in the world. Fort Dodge Animal Health is a world leader in animal health, offering a wide range of vaccines and pharmaceuticals for livestock, swine, horses, dogs, and cats. The Company sells its diversified line of products to wholesalers, pharmacies, hospitals, physicians, retailers and other health care institutions located in various markets in more than 140 countries throughout the world.

Wyeth competes in the healthcare sector under the major drugs industry and participates in the S & P 500 and NYSE. Wyeth's ticker symbol is WYE. Its leading competitors include Johnson & Johnson (JNJ), Bristol Myers Squibb (BMY), Merck & Co. (MRK), and Pfizer (PFE). Wyeth's current market capitalization is approximately $52.4 billion and it trades about 5.13 million shares daily. For the fiscal 2004 year, net sales rose 10% to $17.36 billion. Net income decreased 40% to $1.23 billion which was offset by litigation charges with their diet drug, Fen-phen, which has been linked to potentially fatal heart conditions.